Abstract:Astrocytes are critical for coordinating normal brain function by regulating brain metabolic homeostasis, synaptogenesis and neurotransmission, and blood-brain barrier permeability and maintenance. Dysregulation of normal astrocyte ontogeny contributes to neurodevelopmental and neurodegenerative disorders, epilepsies, and adverse responses to injury. To achieve these multiple essential roles, astrocyte phenotypes are regionally, morphologically, and functionally heterogeneous. Therefore, the best regenerative medicine strategies may require selective production of distinct astrocyte subpopulations at defined maturation levels. However, little is known about the mechanisms that direct astrocyte diversity or whether heterogeneity is represented in biomaterials. In vitro studies report lack of normal morphologies and overrepresentation of the glial scar type of reactive astrocyte morphology and expression of markers, questioning how well the in vitro astrocytes represent glia in vivo and whether in vitro tissue engineering methods are suitable for regenerative medicine applications. Our previous work with neurons suggests that the three-dimensional (3D) environment, when compared with standard two-dimensional (2D) substrate, yields cellular and molecular behaviors that more closely approximately normal ontogeny. To specifically study the effects of dimensionality, we used purified glial fibrillary acidic protein (GFAP)-expressing primary cerebral cortical astrocyte cultures from single pups and characterized the cellular maturation profiles in 2D and 3D milieu. We identified four morphological groups in vitro: round, bipolar, stellate, and putative perivascular. In the 3D hydrogel culture environment, postnatal astrocytes transitioned from a population of nearly all round cells and very few bipolar cells toward a population with significant fractions of round, stellate, and putative perivascular cells within a few days, following the in vivo ontogeny. In 2D, however, the population shift from round and bipolar to stellate and perivascular was rarely observed. The transition to distinct cellular morphologies in 3D corresponded to the in vivo expression of phenotypic markers, supporting the generation of mature heterogeneous glial populations in vitro. This study presents quantitative data supporting that 3D culture is critical for sustaining the heterogeneity of astrocytes in vitro and for generating a representation of the in vivo portfolio of heterogeneous populations of astrocytes required for therapeutic interventions in neurodevelopmental disorders, epilepsy, and brain injury.

Diversity of Reactive Astrogliosis in CNS Pathology: Heterogeneity or Plasticity?

The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics

Astrocyte heterogeneity: an underappreciated topic in neurobiology

Heterogeneity of brain extracellular matrix and astrocyte activation

Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes

Astrocyte Heterogeneity: Impact to Brain Aging and Disease

Regionally diverse astrocyte subtypes and their heterogeneous response to EAE

Reactive astrocyte nomenclature, definitions, and future directions

Reactive Astrocytes in Neurodegenerative Diseases

Astrocytes: biology and pathology

Molecular Diversity Of Astrocytes With Implications For Neurological Disorders

Three-Dimensional Environment Sustains Morphological Heterogeneity and Promotes Phenotypic Progression During Astrocyte Development

Protective Functions of Reactive Astrocytes Following Central Nervous System Insult

Reactive astrogliosis in the era of single-cell transcriptomics

Heterogeneity Analysis of Astrocytes Following Spinal Cord Injury at Single-Cell Resolution.

Astroglial activation: Current concepts and future directions

Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration

Heterogeneity in Synaptogenic Profile of Astrocytes from Different Brain Regions

Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era

The Diverse Roles of Reactive Astrocytes in the Pathogenesis of Amyotrophic Lateral Sclerosis

Astrocytes in human central nervous system diseases: a frontier for new therapies